MX2019005256A - Animales no humanos que tienen un locus de la cadena ligera lambda de inmunoglobulina modificado geneticamente. - Google Patents

Animales no humanos que tienen un locus de la cadena ligera lambda de inmunoglobulina modificado geneticamente.

Info

Publication number
MX2019005256A
MX2019005256A MX2019005256A MX2019005256A MX2019005256A MX 2019005256 A MX2019005256 A MX 2019005256A MX 2019005256 A MX2019005256 A MX 2019005256A MX 2019005256 A MX2019005256 A MX 2019005256A MX 2019005256 A MX2019005256 A MX 2019005256A
Authority
MX
Mexico
Prior art keywords
human
human animals
light chain
chain locus
lambda light
Prior art date
Application number
MX2019005256A
Other languages
English (en)
Inventor
J Murphy Andrew
Macdonald Lynn
Mcwhirter John
Voronina Vera
Harris Faith
Tu Naxin
Guo Chunguang
Levenkova Natasha
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of MX2019005256A publication Critical patent/MX2019005256A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C12N2015/8518—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic expressing industrially exogenous proteins, e.g. for pharmaceutical use, human insulin, blood factors, immunoglobulins, pseudoparticles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se proporcionan animales no humanos (y/o células no humanas) y métodos para usar y producir los mismos, cuyos animales no humanos (y/o células no humanas) tienen un genoma que comprende secuencias que codifican anticuerpos humanos (es decir, genes de inmunoglobulinas). Los animales no humanos descritos en la presente descripción expresan anticuerpos que contienen cadenas ligeras Ig? humanas, en su totalidad o en parte. En particular, los animales no humanos proporcionados en la presente descripción se caracterizan, en algunas modalidades, por la expresión de anticuerpos que contienen cadenas ligeras Ig? humanas, en su totalidad o en parte, que están codificadas por secuencias que codifican cadenas ligeras Ig? humanas insertadas en un locus endógeno de cadena ligera Ig? de dichos animales no humanos. Se proporcionan, además, métodos para producir anticuerpos a partir de animales no humanos.
MX2019005256A 2016-11-04 2017-11-03 Animales no humanos que tienen un locus de la cadena ligera lambda de inmunoglobulina modificado geneticamente. MX2019005256A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662417845P 2016-11-04 2016-11-04
US201762567932P 2017-10-04 2017-10-04
PCT/US2017/060006 WO2018128691A1 (en) 2016-11-04 2017-11-03 Non-human animals having an engineered immunoglobulin lambda light chain locus

Publications (1)

Publication Number Publication Date
MX2019005256A true MX2019005256A (es) 2019-08-05

Family

ID=62025924

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019005256A MX2019005256A (es) 2016-11-04 2017-11-03 Animales no humanos que tienen un locus de la cadena ligera lambda de inmunoglobulina modificado geneticamente.
MX2021010556A MX2021010556A (es) 2016-11-04 2019-05-03 Animales no humanos que tienen un locus de la cadena ligera lambda de inmunoglobulina modificado geneticamente.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021010556A MX2021010556A (es) 2016-11-04 2019-05-03 Animales no humanos que tienen un locus de la cadena ligera lambda de inmunoglobulina modificado geneticamente.

Country Status (24)

Country Link
US (2) US10820582B2 (es)
EP (3) EP3407709B9 (es)
JP (4) JP6884860B2 (es)
KR (4) KR102658529B1 (es)
CN (2) CN109996441B (es)
AU (2) AU2017391167B2 (es)
BR (1) BR112019008675A2 (es)
CA (1) CA3038720A1 (es)
CY (1) CY1123491T1 (es)
DK (2) DK3766343T3 (es)
ES (2) ES2915609T3 (es)
HR (2) HRP20220888T1 (es)
HU (2) HUE061980T2 (es)
IL (2) IL308197A (es)
LT (2) LT3407709T (es)
MA (2) MA44091A (es)
MX (2) MX2019005256A (es)
PL (2) PL3766343T3 (es)
PT (2) PT3766343T (es)
RS (2) RS60886B1 (es)
RU (2) RU2757665C2 (es)
SG (2) SG11201903344XA (es)
SI (2) SI3766343T1 (es)
WO (1) WO2018128691A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2753774T3 (es) * 2012-02-01 2020-04-14 Regeneron Pharma Ratones humanizados que expresan cadenas pesadas que contienen dominios VL
EP3384030A4 (en) 2015-12-03 2019-07-03 Trianni, Inc. IMPROVED IMMUNOGLULINIVITY
DK3766343T3 (da) 2016-11-04 2022-06-20 Regeneron Pharma Ikke-humane dyr med et manipuleret immunoglobulin-lambda-letkædelocus
WO2019190922A1 (en) 2018-03-24 2019-10-03 Regeneron Pharmaceuticals, Inc. Genetically modified non-human animals for generating therapeutic antibodies against peptide-mhc complexes, methods of making and uses thereof
AU2019242586A1 (en) 2018-03-26 2020-10-01 Regeneron Pharmaceuticals, Inc. Humanized rodents for testing therapeutic agents
SI3629720T1 (sl) 2018-06-14 2022-04-29 Regeneron Pharmaceuticals, Inc. Nehumane živali zmožne prerazporeditve DH-DH v kodirnih zaporedjih težke verige imunoglobulina
CN113473850A (zh) 2019-02-22 2021-10-01 瑞泽恩制药公司 具有遗传修饰的钠通道的啮齿动物及其使用方法
KR20220025839A (ko) * 2019-07-01 2022-03-03 트리아니, 인코포레이티드 유전자이식 포유동물 및 이의 사용 방법
EP4211155A1 (en) 2020-09-11 2023-07-19 Regeneron Pharmaceuticals, Inc. Identification and production of antigen-specific antibodies
EP4262373A1 (en) 2020-12-16 2023-10-25 Regeneron Pharmaceuticals, Inc. Mice expressing humanized fc alpha receptors
BR112023011689A2 (pt) 2020-12-23 2023-10-31 Regeneron Pharma Método para obter uma célula produtora de anticorpos, anticorpo, e, célula hospedeira de mamífero
US20220195014A1 (en) 2020-12-23 2022-06-23 Regeneron Pharmaceuticals, Inc. Nucleic acids encoding anchor modified antibodies and uses thereof
GB202217978D0 (en) * 2022-11-30 2023-01-11 Petmedix Ltd Rodents expressing a common light chain

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0746609A4 (en) * 1991-12-17 1997-12-17 Genpharm Int NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES
US5670356A (en) 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
US5874304A (en) 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
GB9823930D0 (en) 1998-11-03 1998-12-30 Babraham Inst Murine expression of human ig\ locus
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7435871B2 (en) 2001-11-30 2008-10-14 Amgen Fremont Inc. Transgenic animals bearing human Igλ light chain genes
WO2005007696A2 (en) * 2003-07-15 2005-01-27 Therapeutic Human Polyclonals, Inc. Humanized immunoglobulin loci
MX2008014804A (es) 2006-06-02 2009-01-27 Regeneron Pharma Anticuerpos de afinidad elevada a receptor de il-6 humano.
AU2009298458B2 (en) 2008-09-30 2015-10-08 Ablexis, Llc Non-human mammals for the production of chimeric antibodies
AU2009329365B2 (en) * 2008-12-18 2016-01-14 Roger Kingdon Craig Non-human transgenic animals expressing humanised antibodies and use thereof
US20120204278A1 (en) * 2009-07-08 2012-08-09 Kymab Limited Animal models and therapeutic molecules
HUE055817T2 (hu) * 2009-07-08 2021-12-28 Kymab Ltd Állatmodellek és terápiás molekulák
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
IL300712A (en) 2010-06-22 2023-04-01 Regeneron Pharma Mice with light chain to human
PL2550363T3 (pl) 2011-02-25 2015-05-29 Regeneron Pharma Myszy adam6
EP3216871B1 (en) 2011-10-17 2021-12-22 Regeneron Pharmaceuticals, Inc. Restricted immunoglobulin heavy chain mice
US9253965B2 (en) 2012-03-28 2016-02-09 Kymab Limited Animal models and therapeutic molecules
PT2793567T (pt) * 2011-12-20 2019-05-27 Regeneron Pharma Murganhos de cadeia leve humanizada
RU2690352C2 (ru) 2013-02-20 2019-05-31 Регенерон Фармасютикалс, Инк. Генетическая модификация крыс
DK2840892T3 (en) * 2013-02-20 2018-07-23 Regeneron Pharma Non-human animals with modified heavy chain immunoglobulin sequences
US9788534B2 (en) * 2013-03-18 2017-10-17 Kymab Limited Animal models and therapeutic molecules
TW201546284A (zh) * 2013-10-01 2015-12-16 Kymab Ltd 動物模式及治療分子
RU2685914C1 (ru) 2013-12-11 2019-04-23 Регенерон Фармасьютикалс, Инк. Способы и композиции для направленной модификации генома
PL3152312T3 (pl) 2014-06-06 2020-08-10 Regeneron Pharmaceuticals, Inc. Sposoby i kompozycje do modyfikowania docelowego locus
PT3155099T (pt) 2014-06-23 2018-04-20 Regeneron Pharma Montagem de dna mediada por nuclease
KR102531016B1 (ko) 2014-11-21 2023-05-10 리제너론 파마슈티칼스 인코포레이티드 쌍 형성된 가이드 rna를 사용하는 표적화된 유전자 변형을 위한 방법 및 조성물
RU2707137C2 (ru) 2014-12-19 2019-11-22 Регенерон Фармасьютикалз, Инк. Способы и композиции для нацеленной генетической модификации посредством одноэтапного множественного нацеливания
DK3766343T3 (da) 2016-11-04 2022-06-20 Regeneron Pharma Ikke-humane dyr med et manipuleret immunoglobulin-lambda-letkædelocus

Also Published As

Publication number Publication date
KR20240055863A (ko) 2024-04-29
US20180125043A1 (en) 2018-05-10
SG10201913483XA (en) 2020-03-30
PL3407709T3 (pl) 2021-01-11
BR112019008675A2 (pt) 2019-07-09
CA3038720A1 (en) 2018-07-12
DK3766343T3 (da) 2022-06-20
RU2019112589A3 (es) 2021-03-30
WO2018128691A1 (en) 2018-07-12
JP2021090455A (ja) 2021-06-17
PT3766343T (pt) 2022-05-30
KR20190076024A (ko) 2019-07-01
JP7386292B2 (ja) 2023-11-24
HUE061980T2 (hu) 2023-09-28
EP3766343A1 (en) 2021-01-20
PL3766343T3 (pl) 2022-09-26
EP3407709B9 (en) 2021-10-06
JP6884860B2 (ja) 2021-06-09
LT3766343T (lt) 2022-06-10
PT3407709T (pt) 2020-08-20
JP2022130725A (ja) 2022-09-06
AU2017391167B2 (en) 2024-02-15
WO2018128691A8 (en) 2019-02-28
NZ753456A (en) 2021-08-27
US10820582B2 (en) 2020-11-03
IL266282B1 (en) 2023-12-01
IL266282B2 (en) 2024-04-01
HUE052087T2 (hu) 2021-04-28
EP4082334A1 (en) 2022-11-02
DK3407709T3 (da) 2020-08-31
IL308197A (en) 2024-01-01
SI3766343T1 (sl) 2022-06-30
RS63390B1 (sr) 2022-08-31
KR102319069B1 (ko) 2021-11-01
CY1123491T1 (el) 2022-03-24
CN109996441B (zh) 2022-02-08
US20210029978A1 (en) 2021-02-04
RU2021129958A (ru) 2021-11-02
EP3766343B1 (en) 2022-05-11
KR102492433B1 (ko) 2023-01-30
RS60886B1 (sr) 2020-11-30
KR102658529B1 (ko) 2024-04-19
KR20210134059A (ko) 2021-11-08
HRP20220888T1 (hr) 2022-10-28
SI3407709T1 (sl) 2020-10-30
HRP20201403T1 (hr) 2020-11-27
ES2823305T3 (es) 2021-05-06
CN114369157A (zh) 2022-04-19
JP2020501516A (ja) 2020-01-23
SG11201903344XA (en) 2019-05-30
MX2021010556A (es) 2021-10-01
EP3407709A1 (en) 2018-12-05
LT3407709T (lt) 2020-10-12
CN109996441A (zh) 2019-07-09
EP3407709B1 (en) 2020-07-29
JP2023053400A (ja) 2023-04-12
IL266282A (en) 2019-06-30
RU2757665C2 (ru) 2021-10-20
KR20230020550A (ko) 2023-02-10
ES2915609T3 (es) 2022-06-23
RU2019112589A (ru) 2020-12-04
AU2024200582A1 (en) 2024-03-28
AU2017391167A1 (en) 2019-05-30
MA53935A (fr) 2021-12-22
MA44091A (fr) 2018-10-24

Similar Documents

Publication Publication Date Title
MX2021010556A (es) Animales no humanos que tienen un locus de la cadena ligera lambda de inmunoglobulina modificado geneticamente.
MX2020005830A (es) Animales no humanos que tienen una cadena ligera lambda de inmunoglobulina modificada y usos de estos.
CY1122036T1 (el) Μη ανθρωπινα ζωα που εκφραζουν αντισωματα τα οποια εχουν μια κοινη ελαφρια αλυσιδα
AR102888A1 (es) Animales no humanos que tienen un gen humanizado de agrupamiento de diferenciación 47
MY172718A (en) Humanized universal light chain mice
PH12016500342A1 (en) Non-human animals having a humanized signal-regulatory protein gene
CY1121798T1 (el) Αντισωματα ελαφριων αλυσιδων τροποποιημενων με ιστιδινη και γενετικα τροποποιημενα ζωα πλην του ανθρωπου για τη δημιουργια αυτων
NZ629639A (en) Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same
MX2018005389A (es) Animales no humanos que tienen un gen 3 de activacion linfocitaria humanizado.
MY178882A (en) Non-human animals with modified immunoglobulin heavy chain sequences
CY1123046T1 (el) Ζωα εκτος του ανθρωπου που εχουν ανθρωποποιημενους υποδοχεις fc-γ
MX353278B (es) Raton con cadena ligera comun.
NZ734504A (en) Humanized rodents that express heavy chains containing vl domains
MX358206B (es) Animales no humanos que tienen un gen humanizado de un ligando inductor de la proliferacion.
MY183188A (en) Non-human animals having a humanized b-cell activating factor gene
MX2015012540A (es) Ratón de cadena ligera común.
MX2021014818A (es) Anticuerpos monoclonales anti-cd303.
PH12020551292A1 (en) Moscato wine replicas produced from individual components
MX2018008701A (es) Roedores que tienen una region de diversidad de cadena pesada modificada geneticamente.
ZA202001389B (en) Non-human animals expressing humanized c1q complex